We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BKI
476
DELISTED
Black Knight, Inc. Common Stock
BKI
| $5.87M | 0.02% |
90,975
-6,152
| -6% | -$381K |
|
477
Northern Trust
NTRS
$22.2B
| $5.86M | 0.02% |
55,177
+10,668
| +24% | +$1.09M |
|
478
Kinder Morgan
KMI
$73.1B
| $5.82M | 0.01% |
274,773
-3,596
| -1% | -$72.8K |
|
479
Edison International
EIX
$30.7B
| $5.74M | 0.01% |
76,167
-557
| -0.7% | -$39.4K |
|
480
Chemed
CHE
$6.78B
| $5.72M | 0.01% |
13,031
-241
| -2% | -$101K |
|
481
Eversource Energy
ES
$28.2B
| $5.71M | 0.01% |
67,146
-7,530
| -10% | -$626K |
|
482
GeoPark
GPRK
$649M
| $5.61M | 0.01% |
254,763
| – | – |
|
483
Cardinal Health
CAH
$53.4B
| $5.6M | 0.01% |
110,624
-7,609
| -6% | -$393K |
|
484
iShares MSCI Japan ETF
EWJ
$21.7B
| $5.59M | 0.01% |
94,445
-19,815
| -17% | -$1.17M |
|
485
H.B. Fuller
FUL
$3B
| $5.55M | 0.01% |
107,561
+9,223
| +9% | +$457K |
|
|
AGN
486
DELISTED
Allergan plc
AGN
| $5.54M | 0.01% |
28,953
-3,986
| -12% | -$719K |
|
487
Welltower
WELL
$178B
| $5.52M | 0.01% |
67,535
-3,412
| -5% | -$292K |
|
488
Monolithic Power Systems
MPWR
$65.5B
| $5.51M | 0.01% |
30,947
-3,970
| -11% | -$634K |
|
489
SBA Communications
SBAC
$18.4B
| $5.51M | 0.01% |
22,848
+2,394
| +12% | +$568K |
|
490
Hewlett Packard
HPE
$63.2B
| $5.5M | 0.01% |
347,016
-9,254
| -3% | -$148K |
|
491
Barclays
BCS
$94.1B
| $5.46M | 0.01% |
573,904
+136,825
| +31% | +$1.18M |
|
492
Cencora
COR
$60.3B
| $5.46M | 0.01% |
64,260
-16,283
| -20% | -$1.4M |
|
493
iShares Broad USD High Yield Corporate Bond ETF
USHY
$28.9B
| $5.42M | 0.01% |
131,943
+169
| +0.1% | +$6.88K |
|
494
Fox Factory Holding Corp
FOXF
$776M
| $5.38M | 0.01% |
77,370
+2,082
| +3% | +$134K |
|
495
Akamai
AKAM
$16.8B
| $5.37M | 0.01% |
62,185
-922
| -1% | -$80.6K |
|
496
Vanguard Mid-Cap Growth ETF
VOT
$19B
| $5.36M | 0.01% |
33,777
+803
| +2% | +$123K |
|
497
Alcon
ALC
$33.1B
| $5.32M | 0.01% |
94,064
-1,792
| -2% | -$103K |
|
498
WPP
WPP
$4.04B
| $5.32M | 0.01% |
75,612
-37,162
| -33% | -$2.36M |
|
499
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.38B
| $5.3M | 0.01% |
179,338
+44,863
| +33% | +$1.31M |
|
500
Mizuho Financial
MFG
$129B
| $5.3M | 0.01% |
1,714,179
-79,293
| -4% | -$247K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.